Clinical Trials Browser

Phase 2 × Small Cell Lung Cancer Extensive Stage × Etoposide × Clear all

NCT05745350 2025-02-11

First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC

Phase 2 Recruiting

Small Cell Lung Cancer Extensive Stage

NCT02179528 2014-09-12

Study of Small Doses of Etoposide as Maintenance Treatment in Small Cell Lung Cancer(SCLC)

Phase 2 Unknown

Small Cell Lung Cancer Extensive Stage